Goldman Sachs... GS looks like a top unless they pump moreLike the prior Idea of mine...most things have given back the Trump-bump election push and are on the way down or skating on thin ice and ready to begin a hard fall.
This has shown similar patterns from previous times.
The lines are hull moving averages or averages that are envelope or 3x exponential. mix them together and you get predictors that are pretty good in general.
Finance
Goldman Sachs ($GS): Trend Channel in FocusGoldman Sachs has been trending higher since our analysis two months ago, prompting us to reevaluate our stance. We’ve concluded that it makes more sense to remain bullish for now and not anticipate a bearish scenario at this stage. We are particularly encouraged by how consistently NYSE:GS has respected its trend channel, which strengthens our belief that it will continue to hold. However, there is a significant concern: we don’t want to see NYSE:GS losing this trend channel or creating a false breakdown, only to trap bears and continue higher.
Goldman Sachs has its earnings call scheduled for the same day as BlackRock and JP Morgan this Wednesday. This adds pressure, and with additional uncertainty from the upcoming political shifts, such as the inauguration of Trump, the potential impact on NYSE:GS , NYSE:BLK , and NYSE:JPM remains unclear.
Setting a limit at the 23.6%-38.2% Fibonacci levels feels too risky given the current environment and the uncertainty in the near future. While we favor this updated bullish scenario over the previous one, the bearish scenario isn’t entirely off the table. It could quickly come back into play if NYSE:GS loses key support levels.
For now, NYSE:GS needs to touch the $536–$489 zone and reclaim the trend channel promptly to validate our bullish scenario. If it fails to do so, we’ll need to approach with extreme caution, and as a result, we are not rushing into a trade at the moment.
BloomZ Inc. Breaks Key Resistance, Signals Bullish MomentumThe share price of BloomZ Inc. (NASDAQ: BLMZ) surged by 7% in pre-market trading, signalling a potential breakout moment for the stock. This sharp move has propelled the price above the critical resistance level of $0.580, which had previously acted as a barrier to upward momentum.
Technical Indicators Favour Bullish Continuation
This breakout is accompanied by a move back above key moving averages, including the 50-day and 200-day MAs, reinforcing the bullish sentiment. These moving averages now serve as dynamic support levels, which can sustain further upward momentum.
The price action is also supported by positive market sentiment and a recent re-rating of BLMZ’s valuation.
Market participants are optimistic about the company’s prospects, contributing to increased trading volume and renewed investor interest. Broader market strength today has further amplified the stock's performance, creating an ideal backdrop for continued gains.
Next Levels to Watch
With the resistance at $0.580 decisively breached, traders are now eyeing the next significant levels around $0.620 and $0.650. Sustained trading above $0.580 could establish a strong base for further bullish activity, while a pullback to retest this level would provide an opportunity to confirm it as new support.
JP Morgan (JPM): Correction on the HorizonJP Morgan ( NYSE:JPM ) is back on our radar as the upcoming earnings season begins, with the banking sector leading the reports. We’ve analyzed JP Morgan before, and the current setup offers intriguing opportunities. Since 2023, the stock has maintained a steady upward trend that continues into 2024.
Currently, NYSE:JPM appears to be in sub-wave ((iii)) within the larger wave (3) or possibly wave 5. However, we anticipate that sub-wave ((iv)) correction is yet to occur, aligning with the broader structural narrative of the chart.
Presently, the stock is trading near a critical trendline originating from the top of sub-wave ((i)). This trendline, which has shifted from resistance to support after multiple touchpoints, now risks being broken. Should it fail, the price could fall from its current level of $243 into a range between $204 and $173. A drop to $173 would represent the maximum correction in our view, while a more realistic pullback would fall within the $204 to $188 range.
On the bullish side, the wave 5 could push up to approximately $260, a modest increase from the current price. This scenario fits within the Elliott Wave framework, anticipating a wave ((iv)) correction before the final upward moves to complete wave 5 and the larger wave (3).
Bullish/Bearish Sentiment We saw #BTC last hit it's double top 209 days after making an ATH 64k in April and topping out in Nov.
VeChain also took around 200 days to revisit higher lows.
[BULLS}
Elliot Wave Theory:
It appears that we are in the next 2-3 wave
Regardless of the narrative, the trend is showing bearish in the short term. I have HODL positions but short until we hit our buy zones keeping a close eye on what #BTC and #ETH do.
CRYPTOCAP:ETH is in a channel and appears to be falling out.
If we dig deeper watch 3k as a psychological area of support, CRYPTOCAP:BTC will be around 95k. For NYSE:VET we see $0.04 being a key level of support in our first buy zone, secondary we are looking for around $0.033.
Once these levels hold I will flip my sentiment and continue to long into this year with our bullish commander and chief stepping into office.
#Donaldtrump
If November repeats itself with this day we could be hopeful for another 300% but remain reserved with our PT's on the way up because.
"You never go broke taking a profit."
HNY #vechain fam.
Don't over-leverage, set your SL before bed.
@VEREKTION
COIN buy setup for near term equity or long call options tradeStrong buy rates indicating we have another solid bounce approaching into end of Jan 2025/ next FOMC meeting, to take price to 302$ target level. Great setup for a long call options trade for 30-45 DTE duration.
Expecting additional volatility after peaking above 300 so will look for discounts once again before seeking entry on calls for Sept.
Weekly and monthly tf cycles analysis indicating COIN share price is preparing to run strongly higher to 750$ and 1000$ targets by early 2026. VERY Very bullish from my standpoint, given its fundamentals and disruption of traditional banking/finance sectors.
Arch up to 120 till the end 2025?So what is Arch Capital - its not an investment bank or fund or something else - lets say insurance company.
Why its so attractive for me right now: Some financial highlights
Robust Profit Growth: In Q3 2024, Arch Capital reported a net income of $978 million ($2.56 per share), up from $713 million ($1.88 per share) in Q3 2023, marking a 37% increase.
Increased Premiums: The company saw a 20% rise in gross premiums written, reaching $5.44 billion in Q3 2024, indicating strong demand for its insurance products.
Enhanced Investment Income: Pre-tax net investment income grew by 48% to $399 million in Q3 2024, reflecting effective investment strategies amid favorable market conditions.
Improved Combined Ratio: Arch Capital achieved a combined ratio of 80.8% in Q1 2024, down from 82.2% in Q1 2023, demonstrating enhanced underwriting efficiency.
Book Value Growth: The company's book value per common share increased by 5.2% to $49.36 as of March 31, 2024, indicating solid financial health.
ANR recommends mstly buy and medium target is near 120
Deutsche Bank: Unlocking New Heights!Deutsche Bank AG ( NYSE:DB is currently trading at $17.48 , reflecting a slight decrease of 0.11% from the previous close.
Our proprietary quantum probability indicator signals a strong buy, suggesting a favorable outlook for the stock.
The technical chart reveals a bullish flag formation, characterized by an initial surge to the $17.20 resistance level, followed by a consolidation phase.
A decisive breakout from this pattern indicates potential for continued upward movement, with a mid-term target of $24.31 .
From a broader perspective, the development of a cup and handle pattern is evident.
This bullish continuation pattern suggests a long-term projection above the major resistance at $27.28.
Recent developments further support this positive outlook.
Deutsche Bank has shifted its stance to "overweight" on European equities, citing lower interest rates and expectations of a strong corporate earnings season amid an improving political landscape.
Analysts highlight that Europe offers the most attractive equity risk premium among developed markets, with the European benchmark index projected to rise by 15% by the end of 2025 .
Additionally, Deutsche Bank's CEO, Christian Sewing , has emphasized the need for structural reforms and reduced regulations to enhance Germany's economic competitiveness, which could positively impact the bank's performance.
In summary, the technical indicators and recent strategic positions of Deutsche Bank point to a positive trajectory, with significant upside potential in both mid-term and long-term projections.
The Rapid Growing Malaysia Health Care SectorMalaysia’s healthcare landscape is entering a transformative phase, underpinned by a robust allocation of RM45.3 billion in the 2025 national budget—a 10% increase compared to 2024. This commitment, the second-largest budget allocation after education, underscores the government’s focus on addressing rising healthcare demands, including an ageing population, chronic diseases, and urban-rural healthcare gaps.
The government’s strategic initiatives, including RM1.3 billion for hospital upgrades and RM300 million for dilapidated clinics in rural areas, highlight a push towards more efficient healthcare delivery. Fitch Solutions’ BMI predicts that Malaysia's healthcare expenditure will grow at an impressive compound annual growth rate (CAGR) of 8.7% from 2023 to 2028, outpacing previous estimates. This growth will be fuelled by increased demand for both public and private healthcare services, bolstered by initiatives such as outsourcing public patient care to 91 private hospitals and the gradual rollback of subsidies for higher-income individuals. The shift in subsidies is expected to drive affluent patients towards private healthcare, expanding opportunities for private healthcare providers.
Private healthcare companies, especially those involved in preventive care and supplements, stand to benefit significantly from these trends. One notable player is Nasdaq-listed Agape ATP Corporation (ATPC), a leading healthcare supplement company in Malaysia. With Malaysia’s emphasis on chronic disease prevention and healthier lifestyles, Agape ATP is well-positioned to meet the rising demand for wellness products. The company’s established reputation and product range make it an attractive choice as the nation prioritises self-sufficiency in medical products and preventive healthcare.
Moreover, the government’s New Industrial Master Plan 2030, aimed at strengthening domestic production of medical products, offers additional prospects for growth. By focusing on advanced diagnostic tools and in-vitro diagnostics, Malaysia is setting the stage for a more globally competitive healthcare ecosystem. As healthcare spending increases and demand for quality services rises, companies like Agape ATP are likely to see enhanced opportunities to expand and thrive. For investors, Malaysia’s growing healthcare sector and its well-aligned private players present a compelling case for long-term value.
"HDFC Bank Swing Trade: Key Levels & 3-Month Investment Plan"A investment idea for HDFCBANK with a holding period of up to 3 months (till Q1). Here’s the analysis based on the marked levels:
Key Levels and Strategy:
1. Entry Point:
1,719.00: Recommended entry level.
2. Take Profit (TP) Targets:
TP 1: 1,778.55
TP 2: 1,818.70
TP 3: 1,906.55 (longer-term target).
3. Stop-Loss (SL) Levels:
SL: 1,697.25 (first risk level, can act as minor support).
Strict SL: 1,671.95 (final stop-loss level to limit risk).
Observations:
Risk-Reward: This strategy provides a well-defined risk-to-reward ratio, with three potential profit levels.
Support Zone: The area around 1,697.25 - 1,671.95 is critical. It might act as strong support if the price drops further.
Resistance Levels:
1,778.55: Could face selling pressure as it aligns with prior resistance.
1,818.70: A stronger resistance where bulls need momentum to break through.
Recommendation:
If the price moves to the entry level (1,719.00), ensure to set your stop-loss and gradually book profits at the mentioned TP levels.
Reassess market conditions if it approaches strict SL (1,671.95) to avoid excessive losses.
Disclaimer:
"I'm not SEBI registered. Please take any trade at your own risk. Market securities are subject to market risks. This is for educational purposes only.
Would you like further insights into technical indicators or additional strategies?
Thank you! Subscribe and like @Alpha_strike_trader."
Bayer AG Analysis: Growth Potential and Positive Buying SentimenThe history of Bayer AG shares goes through many key moments and events:
Foundation and early years: Bayer was founded in 1863 by Friedrich Bayer and Johann Wagner in Germany. The company initially dealt with the production of chemicals and textile dyes.
Development of aspirin: In 1897, Bayer synthesized aspirin, which became one of the most recognizable drugs in the world. This is considered one of the key moments that established the profile of the company.
World War I: During World War I, most of Bayer's assets were confiscated by the Allies, and the company was forced to reorganize.
World War II and post-war period: Bayer, like many German companies, went through significant changes after World War II. A few years later, Bayer joined the newly formed chemical group "Fritz Haber" and focused on innovation.
Diversification and Growth: In the 1970s and 1980s, the company began to diversify into areas such as pharmaceuticals, agronomy, and biotechnology.
Acquisitions and New Products: Bayer AG acquired companies that strengthened its portfolio, including Monsanto in 2018, which provided significant advances in agronomy.
Recent Challenges: In recent years, the company has faced legal challenges and disputes related to its products, particularly glyphosate, the active ingredient in Roundup.
Key Points
Oakmark International fund manager David Herro sees growth potential for Bayer.
The company's agricultural cycle is showing signs of bottoming out.
Bayer AG operates in three main segments: Crop Science, Pharmaceuticals, and Consumer Health.
The Crop Science segment focuses on sustainable agriculture through seeds and crop protection.
The Pharmaceuticals segment offers prescription products, particularly in the areas of cardiology and women's health.
The Consumer Health segment includes nonsteroidal dermatology products and health supplements.
Ryde Group's Big News: Licence Renewal & Share Price SurgeThe following is the transcript of the main video:
A new year gift from Ryde Group Limited (NYSE: RYDE)?
For the followers of RYDE, the big news and rally is finally here. RYDE has officially renewed its ride-hail service operator, and carpool service licenses for another three years.
This is a critical move that reinforces Ryde’s role as a leader in mobility, and quick commerce solutions in Singapore.
Since its launch in 2014, Ryde has revolutionised the industry with its driver-first approach.
Offering a 0% commission policy and unique benefits like a 1-day leave scheme, Ryde empowers drivers to earn more and live better. For riders, its advanced app delivers a seamless booking experience, AI-driven trip recommendations, and faster ride-matching.
RYDE also champions sustainability, expanding its electric vehicle fleet to align with Singapore’s green initiatives. By embracing innovation, the company is shaping a smarter, eco-friendlier urban mobility landscape.
Investors have taken notice too, on this news, RYDE’s share price has doubled, showcasing confidence in its innovative and sustainable vision for the future.
As a fellow investor too, this is a great chance to join into the rally if you missed the bottom!
Ryde Group: A Temporary Downtrend Presents a Long-Term ChanceRyde Group Ltd (NYSE: RYDE), a leading mobility and quick commerce platform from Singapore, has recently experienced a downtrend in its share price. While this might raise concerns, the current dip is best seen as temporary market volatility, not a reflection of the company’s fundamentals. With its recent expansion to serve international travellers, Ryde is positioned for growth, making this an opportunity for forward-looking investors.
On November 1, 2024, Ryde announced its app’s availability for international travellers visiting Singapore, tapping into the city-state's booming tourism industry. This move aligns with the growing demand for convenient and reliable transport services among tourists. The app’s real-time tracking features and global payment options are tailored for travellers, aiming to provide a seamless user experience.
Ryde stands out in the competitive ride-hailing sector with its 0% commission policy, which benefits its driver-partners and ensures a high-quality rider experience. This commitment to safety and fairness continues to attract both users and drivers, strengthening its market position.
The recent decline in Ryde’s share price does not align with its strong fundamentals and growth trajectory. The company’s strategic expansion into tourism, coupled with its innovative business model, positions it for significant revenue growth. Singapore’s rebounding tourism market provides a clear avenue for Ryde to capitalise on increased demand.
For investors, the current dip offers a chance to invest in a company poised for long-term success. As its initiatives gain traction, Ryde’s share price is likely to reflect the underlying growth in its business.
Conclusion
Ryde Group’s recent share price movement is a short-term fluctuation that doesn’t capture the company’s growth potential. With a clear strategy to expand into tourism and a robust operational model, Ryde is positioned for sustainable success. Investors looking for value in the mobility sector should consider this a timely opportunity to enter before the stock rebounds.
In-Depth Technical Review on Agape ATP Corporate (NASDAQ: ATPC)The following is the transcript of the ATPC analysis video.
Agape ATP Corporation’s (NASDAQ: ATPC) daily chart reflects a prolonged period of consolidation, following sharp price volatility earlier in the year.
Notably, the share price has stabilised around the $1.40 to $1.50 range for the past weeks, suggesting that a base may be forming after its earlier decline.
From a technical perspective, the MACD indicator provides valuable insight. The MACD line (represented in blue) has remained close to the signal line (orange) with minimal divergence, indicating a lack of decisive momentum for now.
Additionally, histogram bars oscillate around the zero line, suggesting that buying and selling pressures are relatively balanced.
Turning to the Relative Strength Index (RSI), the indicator is currently hovering around 46.7, which places it in the neutral zone. This suggests that the stock is neither overbought nor oversold, aligning with the lack of a clear directional trend.
A move above 50 could signal increasing bullish momentum, while a drop below 40 would reflect growing selling pressure.
Zooming out, the share price has been in a downtrend since mid-year but appears to have found a floor near the $1.40 level. While short-term volatility has subsided, the lack of volume and weak momentum indicators signal that traders are awaiting a catalyst to trigger the next significant price movement.
In summary, ATPC’s technical indicators – the flat MACD and neutral RSI – suggest the stock is currently in a consolidation phase. Moving forward, traders should monitor any significant breakout above resistance above USD 1.50 level for a trend reversion confirmation.
Velodrome Finance: Key Levels and the Calm Before the Break!!Imagine standing at the edge of a quiet lake in the early morning. The water is still, but you can feel something brewing—a ripple, a shift. That’s where Velodrome Finance (VELO/USD) is right now, hovering around key levels, poised for its next move.
If the price dips to the 50% retracement at $0.23-$0.21, it could find the momentum to push higher. A deeper move to the 61.8% retracement at $0.1770 might still hold promise for a rebound, but if it falls below this level, it’s best to step back and wait for a clearer setup.
On the upside, the target is clear: $0.50. It’s a move that could bring big opportunities, but only if VELO holds strong at these key levels.
This is the kind of moment that defines trading. It’s not about rushing or forcing a move—it’s about watching, waiting, and being ready when the time is right.
Wellness Tip: When the market feels uncertain, take a moment to reset. Step away from the screen, stretch, or just close your eyes for a minute. Trading isn’t just about the moves you make—it’s about staying calm and clear-headed no matter what comes next. 🌿✨
Kris/ Mindbloome Exchange
Trade What You See
Ryde's Zero-Commission Model: A Disruptive Shift!!The e-hailing industry thrives on competition, but few have innovated as boldly as Ryde.
Traditionally, e-hailing platforms operate by charging drivers a commission fee on each trip, often ranging from 10% to 25%.
While this provides platforms with a steady revenue stream, it has long been criticised for cutting into drivers’ take-home pay. Ryde’s new model of zero-commission charged on drivers eliminates this commission structure entirely, ensuring they retain the full fare for every ride.
To make this approach viable, Ryde has introduced a nominal platform fee for riders, charging S$0.55 for trips costing S$18 or less, and S$0.76 for rides above S$18. For non-cash payments, a small transaction fee of 1.9% plus S$0.24 is applied. This transparent pricing strategy balances affordability for riders and operational sustainability for the platform.
By adopting this model, Ryde directly addresses a key pain point in the e-hailing industry: the financial strain faced by drivers. Empowering drivers to earn more from their rides not only increases their financial stability but also fosters greater loyalty to the platform. This innovative approach positions Ryde as a driver-friendly alternative, distinguishing it from competitors that rely heavily on commissions to generate revenue.
For riders, the benefits are equally significant. Ryde’s pricing remains competitive despite the introduction of platform fees. Transparency in fare calculations builds trust among passengers, ensuring they know exactly what they are paying for. In an industry where fare structures are often complex and opaque, this clarity enhances the user experience and strengthens Ryde’s reputation as a reliable and ethical service provider.
Now is the time to watch Ryde closely. Its innovative business model has already begun to draw attention, and the potential for growth is significant. The zero-commission structure is likely to increase driver participation, enabling Ryde to expand its services and reach. Furthermore, its ethical and transparent approach builds trust among both drivers and riders, laying a strong foundation for continued success.
Ryde’s decision to embrace innovation and fairness demonstrates its adaptability in a rapidly evolving industry. This willingness to challenge the status quo makes it more than just another e-hailing platform. Ryde represents a shift towards a more equitable future in ride-hailing, one where drivers, riders, and the platform itself can thrive together. In an era where consumers and stakeholders value ethical practices, Ryde is not just a company to watch—it’s a company worth supporting.
BTCUSD Update: Retest 100K or New Moves Ahead?Good morning, crypto enthusiasts! Today, the fear and greed index remains in extreme greed at 78, while the stochastic RSI has dropped to the oversold area at 9.
In the previous market update, I mentioned the potential for BTC to visit the 93K area. This morning, it dropped to around the 94K price range, which leads me to consider the 93K area invalid. So, where is BTC heading next?
Based on today’s price action, there’s a big probability for a retest of the 100K area. Following this, I see two possible scenarios considering the current extreme greed zone:
A pump to 105K–109K.
A dump to the 90K–85K area.
Stay safe, avoid FOMO, and always manage your risk. That’s all for today’s crypto update. Akki signing off, one chart at a time. Have a nice day and stay SAFU!
HSBC: Opportunities Arises in Southeast Asia’s Healthcare SectorSoutheast Asia's healthcare sector is experiencing a seismic shift, driven by rising affluence, an aging population, and rapid advancements in medical technology. HSBC’s latest outlook highlights the immense growth potential in the region’s healthcare market, underpinned by increasing demand for better medical infrastructure, innovative treatments, and wellness solutions.
With Southeast Asia’s population exceeding 685 million, the region is facing a dramatic demographic transition. By 2050, the proportion of people aged 60 and above is expected to double to 22.2%, creating significant demand for healthcare services, particularly in addressing aging-related conditions like dementia, mental health, and mobility challenges.
While countries like Singapore and Malaysia have relatively high physician-to-population ratios, nations such as Indonesia and the Philippines lag, putting additional strain on already stretched systems.
This demographic shift is compounded by rising wealth, with GDP per capita on a purchasing-power-parity basis projected to reach USD23,260 by 2029. Increased affluence is driving higher healthcare expenditure, with Malaysia and Singapore, for instance, significantly boosting their healthcare budgets in 2024. Across ASEAN, total healthcare expenditure rose by 42% from 2016 to USD156.3 billion in 2021, a trend expected to continue as governments and private entities ramp up investments in the sector.
The region is undergoing a rapid build-out of medical infrastructure, from hospitals and clinics to senior care facilities. Additionally, medical tourism continues to flourish, with Malaysia, Thailand, and Singapore emerging as key destinations. By 2029, the industry is expected to more than double, surpassing USD100 billion annually.
Southeast Asia is grappling with a surge in non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, and cancer. For example, the number of people living with diabetes in Indonesia tripled over the last two decades and is expected to grow by another 47% by 2045. This has spurred demand for innovative treatments, advanced medical equipment, and research collaborations to address these escalating health challenges.
Source: HSBC's Report
While many companies are vying for a share of the expanding Southeast Asian healthcare market, one emerging player, NASDAQ-listed Agape ATP Corporation (ATPC), recently made headlines. The company announced the signing of three Memorandums of Understanding (MOUs) with prominent healthcare institutions in Indonesia.
These agreements aim to advance medical research, introduce innovative treatment strategies, and bolster training programs targeting respiratory diseases like tuberculosis (TB) and chronic obstructive pulmonary disease (COPD). This strategic move positions ATPC as a promising beneficiary of the region’s healthcare transformation and underscores the opportunities for businesses willing to innovate and invest in the sector.
As Southeast Asia's healthcare landscape continues to evolve, companies like ATPC exemplify how strategic initiatives can align with the region’s growing needs, paving the way for sustainable growth in one of the world's fastest-changing markets.
“How Short-Sellers Have Distorted Ryde Group's Share Price"Ryde Group Limited (NYSE) , a promising mobility solutions provider in Southeast Asia, has recently seen its stock price impacted by heightened short-selling activity. While the fundamentals of the company remain solid, the data suggests that aggressive shorting has created a misleading picture of its value, adding volatility and artificial downward pressure to its share price.
As of November 15, 2024, Ryde had 232.67k shares sold short, representing 1.45% of its float of 11.8 million shares. Although the percentage may seem small, Ryde’s low float amplifies the impact of short-selling on price movements.
A smaller float means fewer shares are available for trading, so even a modest short interest can disproportionately sway market sentiment, pushing prices lower than the company’s fundamentals would warrant.
Interestingly, while the short interest decreased significantly from 443.39k shares in the prior month, the presence of short-sellers remains a factor in suppressing the stock’s performance.
The current short ratio of 0.39 suggests that while some short positions are being covered, the lingering activity continues to weigh on investor confidence. This sustained pressure creates a negative feedback loop, where price declines caused by shorting further deter potential buyers, compounding the artificial undervaluation.
Adding to the picture is Ryde’s low institutional ownership, which stands at only 1.06%. Institutions typically provide stability to a stock by holding significant positions and countering speculative trading activity. In Ryde’s case, the limited presence of institutional investors has left the company more vulnerable to short-seller tactics. However, this lack of institutional ownership contrasts sharply with the company’s 34.51% insider ownership, which demonstrates strong internal confidence in Ryde’s long-term growth potential. Such a high percentage of insider holdings suggests that those closest to the company—its executives and key stakeholders—firmly believe in its business model and future prospects.
!The short information above was extracted from Yahoo Finance.
The effects of this short-selling activity are especially concerning because they appear disconnected from Ryde’s underlying fundamentals. Short-sellers often exploit temporary market conditions or investor uncertainty, which can lead to exaggerated declines in stock prices. For a company like Ryde, whose operational and financial health remains stable, this downward pressure creates a misleading narrative that does not align with its true value. Such distortions make it challenging for the market to accurately price the company, potentially causing long-term investors to overlook its potential.
In conclusion, while Ryde’s stock price has been affected by short-sellers, the company’s strong insider confidence and promising fundamentals suggest that its current valuation may not reflect its true worth. Investors who are willing to look beyond the short-term volatility caused by speculative trading may find an opportunity to capitalise on the eventual rebalancing of the market’s perception of Ryde Group Limited.
BTCUSD Update: Correction or Pump to 107K?Good morning, crypto enthusiasts! Today, the fear and greed index remains in extreme greed at 78, while the stochastic RSI is sideways at 40.
From a price action perspective, there’s a higher probability of BTC revisiting the 93K area for a deeper correction. However, there’s a small chance of a pump to around 107K.
Stay safe, avoid FOMO, and always manage your risk. That’s all for today’s crypto update. Akki signing off, one chart at a time. Have a nice day and stay SAFU!
Will Berkshire Hathaway hit $525 before a healthy correction?📈 Introduction Berkshire Hathaway (BRK.B) has shown a consistent pattern of growth over the past years, forming well-defined bullish channels with predictable wave lengths. The current price action suggests a potential healthy correction before another upward rally that could see prices reach the $525 mark.
💡 Key Observations from the Chart
1 - Channel Dynamics:
The price has respected two major ascending channels over the last few years. Each channel has shown waves of sustained upward momentum, lasting approximately 731 days and 790 days, respectively. This consistent cyclicity points to a reliable trend structure.
2 - Correction Phase Ahead?
Based on historical patterns and technical indicators, we might see a short-term correction into the $450-$460 range. This is supported by:
Overbought signals from the Stochastic Oscillator (75/77).
A potential test of the lower boundary of the current ascending channel.
3 - Upside Potential to $525 ~ $550+
After the correction, the next bullish phase could see prices push toward key resistance levels at $491.67 and ultimately $525.90. The confluence of the SMA and VWAP levels reinforces this projection, with strong support near $457.51 acting as a springboard for the next rally.
What’s Next?
The stock remains in a long-term uptrend, and the current dip should be seen as an opportunity rather than a threat. With volatility at 9.63%, the market appears poised for a calculated breakout in the medium term.
What do you think?
BTCUSD Hits 100K, but Is Correction Looming?Good morning, crypto enthusiasts! BTC finally hit the long-awaited 100K milestone, reaching as high as 104K on some exchanges. However, this morning saw a significant drop, breaking through our red zone at 94K-93K.
The fear and greed index has dropped to 72, now in the greed zone. On the H4 timeframe, the stochastic RSI is at 39 and heading toward the oversold area. Looking at the Daily timeframe, BTC has a big chance of continuing its correction, with potential targets in the 84K range, or pushing the fear and greed index toward the neutral zone first.
Currently, there’s no clear sign of another pump for BTC, and even if it happens, it might only retest 100K within our green zone.
Stay safe, avoid FOMO, and always manage your risk. That’s all for today’s crypto update. Akki signing off, one chart at a time. Have a nice day and stay SAFU!